180 related articles for article (PubMed ID: 24872680)
1. Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life.
Guo SP; Wu SG; Zhou J; Feng HX; Li FY; Wu YJ; Sun JY; He ZY
Drug Des Devel Ther; 2014; 8():497-503. PubMed ID: 24872680
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of transdermal fentanyl for the treatment of oral mucositis pain caused by chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Xing SZ; Zhang Y
Support Care Cancer; 2015 Mar; 23(3):753-9. PubMed ID: 25179692
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial.
Hua X; Chen LM; Zhu Q; Hu W; Lin C; Long ZQ; Wen W; Sun XQ; Lu ZJ; Chen QY; Luo DH; Sun R; Mo HY; Tang LQ; Zhang WW; He ZY; Mai HQ; Lin HX; Guo L
Support Care Cancer; 2019 Oct; 27(10):3759-3767. PubMed ID: 30712098
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
Liang L; Liu Z; Zhu H; Wang H; Wei Y; Ning X; Shi Z; Jiang L; Lin Z; Yan H; Wang R; Hu K
Cancer; 2022 Apr; 128(7):1467-1474. PubMed ID: 34910297
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy.
Cai Q; Huang H; Sun X; Xia Z; Li Y; Lin X; Guo Y
Expert Opin Pharmacother; 2008 Dec; 9(18):3137-44. PubMed ID: 19040334
[TBL] [Abstract][Full Text] [Related]
6. [Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation].
Huang HQ; Cai QQ; Lin XB; Wang BF; Bu Q; Gao Y; Peng YL
Ai Zheng; 2007 Apr; 26(4):390-3. PubMed ID: 17430658
[TBL] [Abstract][Full Text] [Related]
7. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients.
Liang G; Du W; Ke Q; Huang B; Yang J
Adv Clin Exp Med; 2017; 26(3):409-413. PubMed ID: 28791814
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma.
Yin J; Xie J; Lin J; Weng C; Lu S; Xu P; Zhang S; Luo C; Huang Y; Li L; Lang J; Feng M
Cancer Biol Ther; 2022 Dec; 23(1):27-33. PubMed ID: 34989325
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation.
Kim JG; Sohn SK; Kim DH; Baek JH; Chae YS; Bae NY; Kim SY; Lee KB
Transplant Proc; 2005 Dec; 37(10):4488-91. PubMed ID: 16387151
[TBL] [Abstract][Full Text] [Related]
11. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
Mitra F; Chowdhury S; Shelley M; Williams G
Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
[TBL] [Abstract][Full Text] [Related]
12. [Effect of smart-phone application on complications of chemoradiotherapy and quality of life in patients with nasopharyngeal carcinoma].
Di RQ; Li GW; Zhao YL; Li XD
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(3):215-218. PubMed ID: 29871226
[No Abstract] [Full Text] [Related]
13. The efficacy of low-dose transdermal fentanyl in opioid-naïve cancer patients with moderate-to-severe pain.
Kang JH; Oh SY; Song SY; Lee HY; Kim JH; Lee KE; Lee HR; Hwang IG; Park SH; Kim WS; Park YS; Park K
Korean J Intern Med; 2015 Jan; 30(1):88-95. PubMed ID: 25589840
[TBL] [Abstract][Full Text] [Related]
14. Effects of Home Nursing Intervention on the Quality of Life of Patients with Nasopharyngeal Carcinoma after Radiotherapy and Chemotherapy.
Shi RC; Meng AF; Zhou WL; Yu XY; Huang XE; Ji AJ; Chen L
Asian Pac J Cancer Prev; 2015; 16(16):7117-21. PubMed ID: 26514499
[TBL] [Abstract][Full Text] [Related]
15. Standardized nursing and clinical efficacy of OxyContin in reducing oral mucosal pain in patients with nasopharyngeal carcinoma: A randomized, double-blind, placebo-controlled study protocol.
Sun N; Li Y; Nie P
Medicine (Baltimore); 2020 Dec; 99(49):e23205. PubMed ID: 33285695
[TBL] [Abstract][Full Text] [Related]
16. Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy.
Zhao C; Chen J; Yu B; Chen X
Int J Radiat Biol; 2014 Oct; 90(10):853-8. PubMed ID: 24758521
[TBL] [Abstract][Full Text] [Related]
17. Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain.
Demarosi F; Lodi G; Soligo D; Sardella A; Volpe AD; Carrassi A; Deliliers GL
Bone Marrow Transplant; 2004 Jun; 33(12):1247-51. PubMed ID: 15094750
[TBL] [Abstract][Full Text] [Related]
18. Transdermal fentanyl improves pain control and functionality in patients with osteoarthritis: an open-label Canadian trial.
Choquette D; McCarthy TG; Rodrigues JF; Kelly AJ; Camacho F; Horbay GL; Husein-Bhabha FA
Clin Rheumatol; 2008 May; 27(5):587-95. PubMed ID: 18038178
[TBL] [Abstract][Full Text] [Related]
19. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
Berliner MN; Giesecke T; Bornhövd KD
Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
[TBL] [Abstract][Full Text] [Related]
20. Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy for locally advanced nasopharyngeal carcinoma: An open labeled, randomized, controlled, and multicenter clinical trial.
Yan P; Yin H; Guo W; Sun X; Li F; Huang S; Bian X; Wang F; Zhang F; Wang B; Zhou H; Zhou C; Yin L; Jiang X; Jiang N; Wu J; Liu J; Song D; He X
Cancer Med; 2020 Sep; 9(17):6166-6172. PubMed ID: 32657029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
